Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan

Haemostatic Imbalance in Patients With Chronic Liver Disease

NCT03589430 ·Status: UNKNOWN

Precision Medicine to Predict the Trajectory of Liver Cirrhosis: Prospective Cohort Study

NCT05899309 ·Status: UNKNOWN

The Natural History and Prognostic Factors of Compensated Cirrhosis.

NCT03144700 ·Status: UNKNOWN

Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study

NCT06619106 ·Status: RECRUITING

To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema

NCT04991259 ·Status: UNKNOWN ·Phase: NA

Impact of Acute Decompensation in Patients of Cirrhosis With or Without Prior Decompensation

NCT03005587 ·Status: WITHDRAWN

Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF

NCT05421351 ·Status: UNKNOWN

Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis

NCT04806581 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

NCT04816916 ·Status: TERMINATED ·Phase: PHASE2

Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage

NCT00553423 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis

NCT05956197 ·Status: UNKNOWN

Gastric Antral Vascular Ectasia in Patients With Cirrhosis: Risk-factors and Associations.

NCT05690750 ·Status: UNKNOWN

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

NCT07132515 ·Status: RECRUITING ·Phase: PHASE4

Microparticles in Cirrhosis and Portal Hypertension

NCT02859610 ·Status: COMPLETED ·Phase: NA

Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)

NCT05140837 ·Status: UNKNOWN

Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy

NCT02156232 ·Status: COMPLETED ·Phase: NA

Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy

NCT00433368 ·Status: COMPLETED ·Phase: PHASE3

Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis

NCT05848414 ·Status: COMPLETED

HepQuant to Predict Hepatic Encephalopathy After TIPS

NCT04664621 ·Status: WITHDRAWN ·Phase: NA

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

NCT00558038 ·Status: COMPLETED ·Phase: PHASE2

To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.

NCT02465619 ·Status: WITHDRAWN

Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury

NCT03204591 ·Status: UNKNOWN

Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE)

NCT01151475 ·Status: COMPLETED

Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy

NCT00955500 ·Status: COMPLETED ·Phase: PHASE4

Unknown Cause of Acute Liver Failure

NCT02041637 ·Status: COMPLETED